Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation

By No Comments
INTRODUCTIONPatients with psoriasis commonly have involvement of the skin fold areas referred to as intertriginous, exural, or inverse psoriasis.These areas are typically marked by less epidermal keratinization and include the…
Read More
Dec 10
Love0

International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary and Data from the Psoriasis Working Group

By No Comments
BACKGROUNDThe International Dermatology Outcome Measures (IDEOM) initiative was established to address limitations of currently used outcome measures, and incorporate input from key relevant stakeholders (patients, health economists and clinicians from…
Read More
Dec 10
Love0

Adalimumab in Chronic Plaque Psoriasis: A Clinical Guide

By No Comments
INTRODUCTIONPsoriasisPsoriasis is a chronic, immune-mediated, inflammatory disease that affects the skin (including the scalp, hands, and feet) and the nails. It affects between 1.5–5% of the population in developed countries,1…
Read More
Dec 10
Love0

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

By No Comments
INTRODUCTIONTreatment of moderate to severe plaque psoriasis has improved substantially with the introduction of treatments that have demonstrated the ability to reduce disease severity and improve quality of life (QOL).1,2…
Read More
Dec 10
Love0

Submammary Granular Parakeratosis Treated With Mastopexy

By No Comments
INTRODUCTIONGranular parakeratosis is a rare disorder of keratinization with a distinctive histology wherein parakeratosis with retention of keratohyaline granules is noted in the epidermis. It was first described in 1991…
Read More
Dec 10
Love0

Twenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature

By No Comments
CASE REPORTA 51-year-old African American female with a history of sickle cell disease, hypertension, and chronic kidney disease presented to our dermatology clinic with discoloration of her fingernails and toenails.…
Read More
Dec 10
Love0

Temporal Association of Herpes Zoster Eruption Post-Aminolevulinic Acid Hydrochloride Photodynamic Therapy for Actinic Keratoses

By No Comments
INTRODUCTIONCASE REPORTDISCUSSIONfatigue, nausea, chills, diarrhea, and rash (not specifically defined in the studies),5-7 but no reports of herpes zoster were found.PDT is proven to be a highly efficacious treatment for…
Read More
Dec 10
Love0

Clinical Review: Secukinumab in Psoriatic Diseases

By No Comments
Read More
Dec 10
Love0

Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of New Biologics Is Important

By No Comments
As clinicians, we tend to eagerly await new drug approvals, especially when the drug represents a new class of treatment and is likely to fulfill an unmet need. We analyze…
Read More
Dec 10
Love0

Secukinumab: Long-term Safety and Efficacy in Psoriasis

By No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated, inflammatory skin disease characterized by erythematous and scaly plaques. The prevalence of psoriasis varies across the globe, with estimates ranging from 0.09% to 5.1% depending…
Read More
Dec 10
Love0

Secukinumab: A Review of Safety and Efficacy in Psoriatic Arthritis

By No Comments
INTRODUCTIONPsoriatic arthritis (PsA) is an immune-mediated, inflammatory disease of the peripheral joints, axial spine, and entheses. The frequency of PsA among patients with psoriasis has been estimated at up to…
Read More
Dec 10
Love0

Effect of a Blueberry-Derived Antioxidant Matrix on Infrared -A Induced Gene Expression in Human Dermal Fibroblasts

By No Comments
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Psoriatic Arthritis Awareness Month May 11, 2026
  • GLP-1 Therapies and Dermatology: A Brief Guide May 7, 2026
  • The Influence of Dermatologists’ Use of Social Media on Attracting Patients May 6, 2026
  • Podcast Refresher: Have You Listened To These Episodes? May 5, 2026
  • Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review May 4, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram